Cardiovascular Risk Evaluations Using a Risk Parameter that Includes an HDL and Inflammatory Biomarker Interaction Parameter

摘要

Methods, systems and circuits evaluate a subject's CVD risk using a risk parameter that includes at least one HDL and inflammatory biomarker interaction parameter. The inflammatory biomarker may optionally comprise NMR derived measurements of GlycA from at least one biosample of the subject. The risk parameter may be gender-specific.